Lenka Novakova
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
The practice effect of smartphone-derived cognitive processing speed assessments as a proxy of cognitive functioning in multiple sclerosis.
Journal: Journal of neurology
Published: February 19, 2026
Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: January 17, 2026
Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 months.
Journal: Journal of neurology
Published: January 16, 2026
Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis.
Journal: European journal of neurology
Published: January 09, 2026
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 17, 2025
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple sclerosis.
Journal: Brain communications
Published: October 02, 2025
Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine implementation.
Journal: Clinical chemistry and laboratory medicine
Published: July 11, 2025
The Effect of Gadolinium on Synthetic Magnetic Resonance Quantitative Imaging.
Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging
Published: June 23, 2025
Plateau of practice effects and noise with repeat SDMT testing in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 31, 2025
Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse activity.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 18, 2025
Brain-Derived Tau as an Outcome Marker in Guillain-Barré Syndrome: A Retrospective Cohort Study.
Journal: European journal of neurology
Published: November 25, 2024
The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use.
Journal: Multiple sclerosis and related disorders
Published: October 30, 2024
Last Updated: 09/26/2026